RSS Updates
Email Updates
One of the largest percentage gainers with data released at the American Society of Clinical Oncology was none other than an OTC micro-cap company called Biovest International, Inc. (OTC: BVTI). Technically, this is a majority owned subsidiary company of Accentia Biopharmaceuticals, Inc. (OTC: ABPIQ). The company has nothing to do with Dendreon Corp. (NASDAQ: DNDN) in the business, but the targets of the potential products use the body’s own immune system to fight tumors strike a similar interest. And this weekend’s data released was far better than most were expecting from a company of this size.
We also covered this one in our weekly “10 Stocks under $10″ Newsletter as one with a big win under its belt. The percentages of success were that large. As noted:
Read More
